Journal of Clinical & Experimental Neuroimmunology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Clin Exp Neuroimmunol 8 : 181,
  • DOI: 10.4172/jceni.1000181

Unbiased Therapeutic Strategy and Resource to the Current Alzheimer?s Therapy

Takashi Kudo*
Department of Mental Health Promotion, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
*Corresponding Author : Takashi Kudo, Department of Mental Health Promotion, Osaka University Graduate School of Medicine, Suita, Osaka, Japan, Email: kudo@psy.med.osaka-u.ac.jp

Received Date: May 02, 2023 / Published Date: May 30, 2023

Abstract

Trace amines are structurally and metabolically associated to classical monoamine neurotransmitters (dopamine, norepinephrine, and serotonin) in the mammalian brain. Under physiological conditions, hint amines are located at low concentrations and modulate numerous physiological strategies along with aminergic neurotransmission. However, they are existing at atypical ranges in many intelligence diseases, implicating their significance in the pathology of various intelligence diseases. Trace amines exert their impact through activating a classification of G-protein-coupled receptors, so-called hint amine-associated receptors (TAARs). TAAR1 is a protein that is expressed in a number of mammalian talent areas, and can be activated with the aid of endogenous hint amines as nicely as via dopaminergic, adrenergic, and serotonergic ligands.

Citation: Kudo T (2023) Unbiased Therapeutic Strategy and Resource to the Current Alzheimer’s Therapy. J Clin Exp Neuroimmunol, 8: 181. Doi: 10.4172/jceni.1000181

Copyright: © 2023 Kudo T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top